{"schema_version":"secwatch.filing_event.v1","accession":"0001410578-25-002072","form_type":"8-K","ticker":"CYPH","cik":"0001509745","company_name":"CYPHERPUNK TECHNOLOGIES INC.","filed_at":"2025-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.171130+00:00","generated_at":"2026-05-17T06:52:24.213265+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Leap Therapeutics gets Nasdaq bid price extension to March 9, 2026","bullets":["Nasdaq granted additional 180-day compliance period until March 9, 2026, for minimum $1.00 bid price.","Initial 180-day period ended Sept. 8, 2025; company met all other listing standards except bid price.","Company may implement a reverse stock split to regain compliance.","No assurance of regaining compliance; delisting could follow if not cured by March 9, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001410578-25-002072","json":"https://secwatch.observer/filing/0001410578-25-002072.json","markdown":"https://secwatch.observer/filing/0001410578-25-002072.md","text":"https://secwatch.observer/filing/0001410578-25-002072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1509745/000141057825002072/0001410578-25-002072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1509745/000141057825002072/tm2525891d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:52:24.213265+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ba7d0e2c8b8b1997acac54024cd3a2bc1047b769","claim":"CYPHERPUNK TECHNOLOGIES INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"September 8, 2025, to regain compliance with Rule 5550(a)(2) by maintaining a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. Additionally, Nasdaq notified the Company that it might be eligible for an additional compliance period of 180 calendar days if, on September 8, 2025, the Company met the continued listing requirement for market value of publicly held shares and all other applicable standards for initial listing on the Nasdaq Capital Market (with the exception of the closing bid price requirement) based on the Company’s then most recent publi","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1509745/000141057825002072/0001410578-25-002072-index.htm","confidence":0.82,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}